- Research works
- 24 ▼ 38% vs 2013–17
- Citations
- 623 26.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: APR Technologies (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 11.7×
- Immunology and Microbiology 5.5×
- Arts and Humanities 4.3×
- Chemistry 2.6×
- Computer Science 1.8×
- Social Sciences 1.3×
- Medicine 1.1×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Physics and Astronomy 0.9×
- Engineering 0.7×
- Materials Science 0.6×
- Environmental Science 0.6×
Which keywords describe research at APR Technologies (Sweden)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Apoptosis, Cell Cycle, p53, Immunotherapy, Chemotherapy, Biomarkers and Prognostic Factors.
- Small-Cell Lung Cancer
- Metastasis
- Identity
- Colonialism
- Innovation
- Biomarkers
- p53
- Apoptosis
- Cancer Therapy
- Cell Cycle
- Immunotherapy
- Chemotherapy
- Clinical Trials
- Globalization
- Prognostic Factors
- Genomic Profiles
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cancer Therapy2▲ 16×6 topics
- Apoptosis2▲ 21×2 topics
- Cell Cycle2▲ 134×1 topic
- p532▲ 178×1 topic
- Immunotherapy2▲ 11×4 topics
- Biomarkers1▲ 8.7×4 topics
- Chemotherapy1▲ 8.1×4 topics
- Innovation1▲ 5.9×5 topics
- Clinical Trials1▲ 8.2×3 topics
- Colonialism1▲ 10.0×3 topics
- Globalization1▲ 2.7×3 topics
- Identity1▲ 6.5×3 topics
- Prognostic Factors1▲ 11×4 topics
- Metastasis1▲ 14×2 topics
- Genomic Profiles1▲ 126×1 topic
- Small-Cell Lung Cancer1▲ 126×1 topic
Which research topics does APR Technologies (Sweden) publish most on?
By volume in 2022–2025: Historical Studies and Socio-cultural Analysis, Diverse Cultural and Historical Studies, Multiculturalism, Politics, Migration, Gender and Subtitles and Audiovisual Media.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Historical Studies and Socio-cultural Analysis History and Philosophy of Science 0 works
- 2 Diverse Cultural and Historical Studies Cultural Studies 0 works
- 3 Multiculturalism, Politics, Migration, Gender Political Science and International Relations 0 works
- 4 Subtitles and Audiovisual Media Language and Linguistics 0 works
- 5 Pharmacy and Medical Practices Pharmacology 0 works
- 6 Video Analysis and Summarization Computer Vision and Pattern Recognition 0 works
- 7 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
- 8 Multimodal Machine Learning Applications Computer Vision and Pattern Recognition 0 works
- 9 Maritime Transport Emissions and Efficiency Environmental Engineering 0 works
- 10 Advanced battery technologies research Electrical and Electronic Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has APR Technologies (Sweden)'s research output changed?
Output in 2018–2022 was 38% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.